CONCENTRIX CORP (CNXC) Stock Fundamental Analysis

NASDAQ:CNXC • US20602D1019

30.385 USD
+0.14 (+0.46%)
At close: Feb 13, 2026
30.28 USD
-0.11 (-0.35%)
After Hours: 2/13/2026, 8:00:42 PM
Fundamental Rating

4

Taking everything into account, CNXC scores 4 out of 10 in our fundamental rating. CNXC was compared to 87 industry peers in the IT Services industry. While CNXC is still in line with the averages on profitability rating, there are concerns on its financial health. CNXC has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CNXC was profitable.
  • CNXC had a positive operating cash flow in the past year.
  • CNXC had positive earnings in 4 of the past 5 years.
  • Of the past 5 years CNXC 4 years had a positive operating cash flow.
CNXC Yearly Net Income VS EBIT VS OCF VS FCFCNXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

  • The Return On Assets of CNXC (2.43%) is comparable to the rest of the industry.
  • CNXC has a Return On Equity (6.95%) which is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 5.58%, CNXC perfoms like the industry average, outperforming 59.77% of the companies in the same industry.
  • CNXC had an Average Return On Invested Capital over the past 3 years of 7.17%. This is below the industry average of 10.59%.
Industry RankSector Rank
ROA 2.43%
ROE 6.95%
ROIC 5.58%
ROA(3y)3.63%
ROA(5y)4.4%
ROE(3y)9.77%
ROE(5y)10.34%
ROIC(3y)7.17%
ROIC(5y)7.81%
CNXC Yearly ROA, ROE, ROICCNXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of CNXC (3.10%) is comparable to the rest of the industry.
  • CNXC's Profit Margin has been stable in the last couple of years.
  • CNXC's Operating Margin of 7.43% is fine compared to the rest of the industry. CNXC outperforms 64.37% of its industry peers.
  • CNXC's Operating Margin has been stable in the last couple of years.
  • CNXC has a Gross Margin (35.28%) which is in line with its industry peers.
  • CNXC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.43%
PM (TTM) 3.1%
GM 35.28%
OM growth 3Y-7.9%
OM growth 5Y0.21%
PM growth 3Y-29.45%
PM growth 5Y0.19%
GM growth 3Y0.57%
GM growth 5Y-0.7%
CNXC Yearly Profit, Operating, Gross MarginsCNXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNXC is destroying value.
  • Compared to 1 year ago, CNXC has less shares outstanding
  • Compared to 5 years ago, CNXC has more shares outstanding
  • The debt/assets ratio for CNXC is higher compared to a year ago.
CNXC Yearly Shares OutstandingCNXC Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CNXC Yearly Total Debt VS Total AssetsCNXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 1.37, we must say that CNXC is in the distress zone and has some risk of bankruptcy.
  • CNXC has a worse Altman-Z score (1.37) than 64.37% of its industry peers.
  • CNXC has a debt to FCF ratio of 9.36. This is a negative value and a sign of low solvency as CNXC would need 9.36 years to pay back of all of its debts.
  • CNXC has a Debt to FCF ratio of 9.36. This is comparable to the rest of the industry: CNXC outperforms 47.13% of its industry peers.
  • CNXC has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
  • CNXC has a worse Debt to Equity ratio (1.10) than 67.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 9.36
Altman-Z 1.37
ROIC/WACC0.72
WACC7.78%
CNXC Yearly LT Debt VS Equity VS FCFCNXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • CNXC has a Current Ratio of 1.56. This is a normal value and indicates that CNXC is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, CNXC is in line with its industry, outperforming 44.83% of the companies in the same industry.
  • CNXC has a Quick Ratio of 1.56. This is a normal value and indicates that CNXC is financially healthy and should not expect problems in meeting its short term obligations.
  • CNXC has a Quick ratio of 1.56. This is comparable to the rest of the industry: CNXC outperforms 44.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
CNXC Yearly Current Assets VS Current LiabilitesCNXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2

3. Growth

3.1 Past

  • CNXC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.49%.
  • Measured over the past years, CNXC shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.50% on average per year.
EPS 1Y (TTM)-1.49%
EPS 3Y-1.5%
EPS 5YN/A
EPS Q2Q%-9.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.29%

3.2 Future

  • CNXC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.68% yearly.
  • CNXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.90% yearly.
EPS Next Y7.86%
EPS Next 2Y9.23%
EPS Next 3Y11.68%
EPS Next 5YN/A
Revenue Next Year3.3%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CNXC Yearly Revenue VS EstimatesCNXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
CNXC Yearly EPS VS EstimatesCNXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 2.71, the valuation of CNXC can be described as very cheap.
  • 97.70% of the companies in the same industry are more expensive than CNXC, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of CNXC to the average of the S&P500 Index (27.97), we can say CNXC is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 2.51, the valuation of CNXC can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, CNXC is valued cheaply inside the industry as 98.85% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 27.96. CNXC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.71
Fwd PE 2.51
CNXC Price Earnings VS Forward Price EarningsCNXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 95.40% of the companies in the same industry are more expensive than CNXC, based on the Enterprise Value to EBITDA ratio.
  • 95.40% of the companies in the same industry are more expensive than CNXC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.67
EV/EBITDA 4.59
CNXC Per share dataCNXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • CNXC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y9.23%
EPS Next 3Y11.68%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.70%, CNXC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.50, CNXC pays a better dividend. On top of this CNXC pays more dividend than 98.85% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.79, CNXC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

  • CNXC has been paying a dividend for over 5 years, so it has already some track record.
  • CNXC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
CNXC Yearly Dividends per shareCNXC Yearly Dividends per shareYearly Dividends per share 2016 2017 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • CNXC pays out 29.50% of its income as dividend. This is a sustainable payout ratio.
DP29.5%
EPS Next 2Y9.23%
EPS Next 3Y11.68%
CNXC Yearly Income VS Free CF VS DividendCNXC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CNXC Dividend Payout.CNXC Dividend Payout, showing the Payout Ratio.CNXC Dividend Payout.PayoutRetained Earnings

CONCENTRIX CORP

NASDAQ:CNXC (2/13/2026, 8:00:42 PM)

After market: 30.28 -0.11 (-0.35%)

30.385

+0.14 (+0.46%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)01-13
Earnings (Next)03-24
Inst Owners100.4%
Inst Owner Change-1.3%
Ins Owners0.58%
Ins Owner Change0.79%
Market Cap1.89B
Revenue(TTM)N/A
Net Income(TTM)301.81M
Analysts81.82
Price Target57.89 (90.52%)
Short Float %16.6%
Short Ratio7.61
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend1.29
Dividend Growth(5Y)N/A
DP29.5%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-30
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.32%
Min EPS beat(2)-4.97%
Max EPS beat(2)-3.67%
EPS beat(4)2
Avg EPS beat(4)0.88%
Min EPS beat(4)-4.97%
Max EPS beat(4)6.25%
EPS beat(8)4
Avg EPS beat(8)0.59%
EPS beat(12)4
Avg EPS beat(12)-1.72%
EPS beat(16)7
Avg EPS beat(16)-0.64%
Revenue beat(2)0
Avg Revenue beat(2)-0.75%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.48%
Revenue beat(4)0
Avg Revenue beat(4)-1.2%
Min Revenue beat(4)-1.65%
Max Revenue beat(4)-0.48%
Revenue beat(8)0
Avg Revenue beat(8)-1.1%
Revenue beat(12)0
Avg Revenue beat(12)-1.81%
Revenue beat(16)0
Avg Revenue beat(16)-1.87%
PT rev (1m)-10.77%
PT rev (3m)-12.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 2.71
Fwd PE 2.51
P/S 0.19
P/FCF 3.67
P/OCF 2.53
P/B 0.44
P/tB N/A
EV/EBITDA 4.59
EPS(TTM)11.22
EY36.93%
EPS(NY)12.1
Fwd EY39.83%
FCF(TTM)8.28
FCFY27.27%
OCF(TTM)12
OCFY39.49%
SpS156.13
BVpS69.77
TBVpS-47.01
PEG (NY)0.34
PEG (5Y)N/A
Graham Number132.72
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 6.95%
ROCE 6.94%
ROIC 5.58%
ROICexc 5.77%
ROICexgc 20.88%
OM 7.43%
PM (TTM) 3.1%
GM 35.28%
FCFM 5.31%
ROA(3y)3.63%
ROA(5y)4.4%
ROE(3y)9.77%
ROE(5y)10.34%
ROIC(3y)7.17%
ROIC(5y)7.81%
ROICexc(3y)7.36%
ROICexc(5y)8.08%
ROICexgc(3y)28.93%
ROICexgc(5y)27.59%
ROCE(3y)8.91%
ROCE(5y)9.71%
ROICexgc growth 3Y-8.2%
ROICexgc growth 5Y-1.87%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-3.98%
OM growth 3Y-7.9%
OM growth 5Y0.21%
PM growth 3Y-29.45%
PM growth 5Y0.19%
GM growth 3Y0.57%
GM growth 5Y-0.7%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 9.36
Debt/EBITDA 3.46
Cap/Depr 34.88%
Cap/Sales 2.38%
Interest Coverage 250
Cash Conversion 53.94%
Profit Quality 170.91%
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 1.37
F-Score7
WACC7.78%
ROIC/WACC0.72
Cap/Depr(3y)41.85%
Cap/Depr(5y)48.26%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.71%
Profit Quality(3y)148.84%
Profit Quality(5y)148.37%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.49%
EPS 3Y-1.5%
EPS 5YN/A
EPS Q2Q%-9.51%
EPS Next Y7.86%
EPS Next 2Y9.23%
EPS Next 3Y11.68%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.29%
Revenue Next Year3.3%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.17%
EBIT growth 3Y10.38%
EBIT growth 5Y15.6%
EBIT Next Year24.21%
EBIT Next 3Y9.66%
EBIT Next 5YN/A
FCF growth 1Y-1.93%
FCF growth 3Y5.5%
FCF growth 5Y4.83%
OCF growth 1Y9.16%
OCF growth 3Y9.09%
OCF growth 5Y8.22%

CONCENTRIX CORP / CNXC FAQ

What is the ChartMill fundamental rating of CONCENTRIX CORP (CNXC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CNXC.


Can you provide the valuation status for CONCENTRIX CORP?

ChartMill assigns a valuation rating of 8 / 10 to CONCENTRIX CORP (CNXC). This can be considered as Undervalued.


How profitable is CONCENTRIX CORP (CNXC) stock?

CONCENTRIX CORP (CNXC) has a profitability rating of 4 / 10.


What are the PE and PB ratios of CONCENTRIX CORP (CNXC) stock?

The Price/Earnings (PE) ratio for CONCENTRIX CORP (CNXC) is 2.71 and the Price/Book (PB) ratio is 0.44.


Can you provide the expected EPS growth for CNXC stock?

The Earnings per Share (EPS) of CONCENTRIX CORP (CNXC) is expected to grow by 7.86% in the next year.